Coronary Artery Disease: Optimal Lipoprotein(a) for Survival—Lower Is Better? A Large Cohort With 43,647 Patients

Coronary Artery Disease: Optimal Lipoprotein(a) for Survival—Lower Is Better? A Large Cohort With 43,647 Patients

Background: A high level of lipoprotein(a) can lead to a high risk of cardiovascular events or mortality. However, the association of moderately elevated lipoprotein(a) levels (≥15 mg/dL) with long-term prognosis among patients with coronary artery disease (CAD) is still uncertain. Hence, we aim to...

Full description

Bibliographic Details
Main Authors: Jin Liu, Liwei Liu, Bo Wang, Shiqun Chen, Buyun Liu, Jingjing Liang, Haozhang Huang, Qiang Li, Zhubin Lun, Ming Ying, Guanzhong Chen, Zhidong Huang, Danyuan Xu, Xiaoming Yan, Tingting Zhu, Girmaw Abebe Tadesse, Ning Tan, Jiyan Chen, Yong Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
coronary artery disease
baseline lipoprotein(a)
long-term all-cause mortality
percutaneous coronary intervention
coronary angiography
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.670859/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.670859/full

Similar Items